First Trust Advisors LP grew its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 538.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 73,259 shares of the company’s stock after purchasing an additional 61,792 shares during the quarter. First Trust Advisors LP owned about 0.14% of Prestige Consumer Healthcare worth $2,812,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. Citadel Advisors LLC grew its position in Prestige Consumer Healthcare by 130.7% during the first quarter. Citadel Advisors LLC now owns 219,862 shares of the company’s stock worth $7,414,000 after buying an additional 124,560 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in Prestige Consumer Healthcare during the first quarter worth approximately $683,000. Wells Fargo & Company MN grew its position in Prestige Consumer Healthcare by 46.4% during the first quarter. Wells Fargo & Company MN now owns 1,837,285 shares of the company’s stock worth $61,954,000 after buying an additional 582,373 shares in the last quarter. Royal Bank of Canada grew its position in Prestige Consumer Healthcare by 81.4% during the first quarter. Royal Bank of Canada now owns 2,027,327 shares of the company’s stock worth $68,362,000 after buying an additional 909,507 shares in the last quarter. Finally, Eagle Boston Investment Management Inc. grew its position in Prestige Consumer Healthcare by 4.6% during the first quarter. Eagle Boston Investment Management Inc. now owns 250,987 shares of the company’s stock worth $8,463,000 after buying an additional 11,135 shares in the last quarter.
Shares of NYSE:PBH opened at $38.38 on Friday. The company has a market cap of $1.99 billion, a P/E ratio of 14.88, a P/E/G ratio of 1.57 and a beta of 1.04. Prestige Consumer Healthcare Inc has a 1 year low of $27.84 and a 1 year high of $51.79. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.37 and a current ratio of 2.21.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $0.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.67 by $0.01. The business had revenue of $253.98 million for the quarter, compared to the consensus estimate of $253.70 million. Prestige Consumer Healthcare had a return on equity of 12.45% and a net margin of 32.76%. The firm’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.66 earnings per share. analysts anticipate that Prestige Consumer Healthcare Inc will post 2.86 EPS for the current fiscal year.
A number of equities research analysts recently issued reports on PBH shares. Zacks Investment Research downgraded Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 10th. Jefferies Financial Group set a $38.00 price target on Prestige Consumer Healthcare and gave the stock a “hold” rating in a research report on Thursday, August 2nd. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $69.00.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Recommended Story: New Google Finance Tool and Screening Stocks
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.